144 related articles for article (PubMed ID: 36519119)
1. Adoption and Trends in Uptake of Updated ICD-10 Codes for
Deshpande A; Chen Y; Boye-Codjoe E; Obi EN
Open Forum Infect Dis; 2022 Dec; 9(12):ofac622. PubMed ID: 36519119
[TBL] [Abstract][Full Text] [Related]
2. Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of
de la Villa S; Herrero S; Muñoz P; Rodríguez C; Valerio M; Reigadas E; Álvarez-Uría A; Alcalá L; Marín M; Olmedo M; Kestler M; Chamorro E; Bouza E
Open Forum Infect Dis; 2023 Feb; 10(2):ofad028. PubMed ID: 36776780
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of
Dubberke ER; Gerding DN; Kelly CP; Garey KW; Rahav G; Mosley A; Tipping R; Dorr MB
Open Forum Infect Dis; 2020 Jun; 7(6):ofaa157. PubMed ID: 32523972
[TBL] [Abstract][Full Text] [Related]
4. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
Madoff SE; Urquiaga M; Alonso CD; Kelly CP
Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Huang AM; Marini BL; Frame D; Aronoff DM; Nagel JL
Transpl Infect Dis; 2014 Oct; 16(5):744-50. PubMed ID: 25040545
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease.
You JHS; Jiang X; Lee WH; Chan PKS; Ng SC
J Gastroenterol Hepatol; 2020 Sep; 35(9):1515-1523. PubMed ID: 32017248
[TBL] [Abstract][Full Text] [Related]
7. Healthcare resource utilization and direct medical costs associated with index and recurrent
Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
[No Abstract] [Full Text] [Related]
8. Real-world Experience of Bezlotoxumab for Prevention of
Hengel RL; Ritter TE; Nathan RV; Van Anglen LJ; Schroeder CP; Dillon RJ; Marcella SW; Garey KW
Open Forum Infect Dis; 2020 Apr; 7(4):ofaa097. PubMed ID: 32363211
[TBL] [Abstract][Full Text] [Related]
9. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
[TBL] [Abstract][Full Text] [Related]
10. Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with
Amin A; Nelson WW; Dreyfus J; Wong AC; Mohammadi I; Teigland C; Dahdal DN; Feuerstadt P
Ther Adv Infect Dis; 2022; 9():20499361221095679. PubMed ID: 35510091
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for Clostridium difficile infection: ICD-9 coding has poor sensitivity compared to laboratory diagnosis in hospital patients, Singapore.
Chan M; Lim PL; Chow A; Win MK; Barkham TM
PLoS One; 2011 Jan; 6(1):e15603. PubMed ID: 21283751
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States.
El Halabi J; Palmer N; Fox K; Kohane I; Farhat MR
J Gastroenterol; 2022 Jan; 57(1):10-18. PubMed ID: 34495400
[TBL] [Abstract][Full Text] [Related]
13. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
[TBL] [Abstract][Full Text] [Related]
15. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
[TBL] [Abstract][Full Text] [Related]
16. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
17. Investigational Treatment Agents for Recurrent
Kullar R; Tran MN; Goldstein EJC
J Exp Pharmacol; 2020; 12():371-384. PubMed ID: 33116952
[No Abstract] [Full Text] [Related]
18. Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence.
Johnson TM; Molina KC; Howard AH; Schwarz K; Allen L; Huang M; Bajrovic V; Miller MA
Clin Infect Dis; 2022 May; 74(9):1572-1578. PubMed ID: 34665248
[TBL] [Abstract][Full Text] [Related]
19. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
Gerding DN; Kelly CP; Rahav G; Lee C; Dubberke ER; Kumar PN; Yacyshyn B; Kao D; Eves K; Ellison MC; Hanson ME; Guris D; Dorr MB
Clin Infect Dis; 2018 Aug; 67(5):649-656. PubMed ID: 29538686
[TBL] [Abstract][Full Text] [Related]
20. Bezlotoxumab in Patients with a Primary
Granata G; Schiavone F; Pipitone G
Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
